2014
DOI: 10.1007/s00592-014-0662-3
|View full text |Cite
|
Sign up to set email alerts
|

Endotoxemia, nutrition, and cardiometabolic disorders

Abstract: A high serum LPS activity is strongly associated with cardiometabolic disorders, which supports the role of bacterial infections and immune response in their etiology.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

6
93
1
4

Year Published

2015
2015
2024
2024

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 113 publications
(104 citation statements)
references
References 35 publications
6
93
1
4
Order By: Relevance
“…Higher circulating LPS levels were associated with an increased risk of type 2 diabetes [25], metabolic syndrome [25], and coronary heart disease [26] in humans. A chronic subcutaneous infusion of low-dose LPS-induced glucose intolerance, insulin resistance, and increased adiposity in mice [27], and thus, chronic exposure to low levels of LPS may be causally related to metabolic disorders.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Higher circulating LPS levels were associated with an increased risk of type 2 diabetes [25], metabolic syndrome [25], and coronary heart disease [26] in humans. A chronic subcutaneous infusion of low-dose LPS-induced glucose intolerance, insulin resistance, and increased adiposity in mice [27], and thus, chronic exposure to low levels of LPS may be causally related to metabolic disorders.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, RYGB or duodenal switch has been reported to decrease plasma lipopolysaccharide (LPS) levels in obese human subjects with or without type 2 diabetes [24]. Increased plasma LPS levels were associated with incident type 2 diabetes [25], metabolic syndrome [25], and coronary heart disease [26] in humans. In mice, a chronic subcutaneous infusion of low-dose LPS produced glucose intolerance, insulin resistance, and obesity, which was associated with an increased expression of inflammatory genes in the liver, fat, and muscles [27].…”
Section: Introductionmentioning
confidence: 99%
“…Inflammation mediators, such as lipopolysaccharide and cytokines, may spread systemically promoting cardiometabolic disorders (Pussinen et al 2007;Pussinen et al 2011;Lockhart et al 2012;Schenkein and Loos 2013;Kallio et al 2014).…”
Section: Introductionmentioning
confidence: 99%
“…Perturbation of the microbiota composition, also known as dysbiosis, has been observed in obesity, partly due to a strong decrease in the bacterial diversity [4]. In addition, the gram-negative cell wall component Lipopolysaccharide (LPS) translocation might induce metabolic endotoxemia, chronic low-grade inflammation, and ultimately insulin resistance [5,6]. This fact is also related to metabolic syndrome, and eventually to gastroesophageal reflux and esophagitis.…”
Section: Introductionmentioning
confidence: 99%
“…
years, probiotics have been shown to have a beneficial effect on obesity and insulin resistance [8,6].
…”
mentioning
confidence: 99%